KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Elevance Health (ELV) EBIAT (2016 - 2025)

Elevance Health (ELV) has disclosed EBIAT for 17 consecutive years, with $547.0 million as the latest value for Q4 2025.

  • Quarterly EBIAT rose 32.45% to $547.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.7 billion through Dec 2025, down 5.18% year-over-year, with the annual reading at $5.7 billion for FY2025, 5.18% down from the prior year.
  • EBIAT for Q4 2025 was $547.0 million at Elevance Health, down from $1.2 billion in the prior quarter.
  • The five-year high for EBIAT was $2.3 billion in Q2 2024, with the low at $413.0 million in Q4 2024.
  • Average EBIAT over 5 years is $1.5 billion, with a median of $1.6 billion recorded in 2022.
  • The sharpest move saw EBIAT surged 576.58% in 2021, then crashed 51.98% in 2024.
  • Over 5 years, EBIAT stood at $1.2 billion in 2021, then dropped by 27.69% to $859.0 million in 2022, then increased by 0.12% to $860.0 million in 2023, then crashed by 51.98% to $413.0 million in 2024, then skyrocketed by 32.45% to $547.0 million in 2025.
  • According to Business Quant data, EBIAT over the past three periods came in at $547.0 million, $1.2 billion, and $1.7 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.